PulmoScience

PulmoScience is a Montreal-based biotechnology company focused on developing precision medicine tools for pulmonary vascular diseases. The company's flagship product, PulmoBind, is a patented radiopharmaceutical peptide used for molecular imaging of the pulmonary circulation. It specifically targets adrenomedullin receptors to provide a non-invasive assessment of pulmonary vascular health, particularly in patients with pulmonary arterial hypertension (PAH). PulmoScience's technology originated from research at the Montreal Heart Institute and aims to improve early diagnosis and treatment monitoring for rare respiratory conditions. The company is currently advancing its lead candidate through clinical trials to validate its efficacy as a functional imaging biomarker.